(Q39440265)
Statements
Combined treatment of the immunoconjugate bivatuzumab mertansine and fractionated irradiation improves local tumour control in vivo (English)
Kristin Gurtner
Franziska Hessel
Wolfgang Eicheler
Annegret Dörfler
Karl-Heinz Heider
17 November 2011